Kessel Dermatology logo

Xeomin®

Xeomin®

Xeomin® services offered in Hamilton Square, Trenton, and Mercer County area, New Jersey

Xeomin is a neuromodulating product very similar to Botox Cosmetic. It is made by a different company and while the effect on the muscle, it’s duration of effect and dosing are nearly the same, there are a couple differences.

Mainly, Xeomin is a purified protein product. That means there are no other ingredients like proteins are additives which makes it less likely that a patient will develop a resistance to its effect and a great choice for any patients who are developing a resistance to Botox. At Kessel Dermatology, servicing the Hamilton Square, Trenton, and Mercer County areas in New Jersey, we offer this treatment as an alternative to Botox.

Some Frequently Asked Questions

xeominWHAT IS XEOMIN®?

Xeomin® (incobotulinumtoxinA) is a prescription medication injected into muscles and used to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines) in adults. Xeomin® contains botulinum toxin type A, a protein purified from the bacterium Clostridium botulinum.

HOW DOES XEOMIN® WORK?

When you squint or frown, the muscles between your eyebrows contract, causing the skin to furrow and fold. Over time, as your skin ages and loses some of its elasticity, these repeated contractions can cause persistent frown lines. Botulinum toxin type A – the active ingredient in Xeomin®– acts on nerve endings in muscles to prevent muscle fibers from contracting. By reducing these contractions, Xeomin® can temporarily reduce the lines between your eyebrows

IS XEOMIN® PROVEN?

Xeomin® was proven effective in two randomized, double-blind, multicenter, placebo-controlled clinical trials of 547 healthy, adult patients. The average age of patients in the study was 46 years. Patients received 20 Units of Xeomin® and were classified as responders if they had a 2-grade improvement on a 4-point scale as assessed by the physician and patient. Using these criteria, treatment success was higher with Xeomin® than placebo on Day 30 in both studies (60% and 48% vs. 0% for placebo in both studies). Based on these trials, Xeomin® received FDA approval for use in glabellar lines in 2011.

WHAT SHOULD I TELL MY DOCTOR BEFORE TREATMENT?

Before receiving treatment with Xeomin®, you should tell your doctor about all of your medical conditions, including whether you have a disease that affects your muscles and nerves, have allergies to any botulinum toxin product, or have experienced any side effect from any other botulinum toxin in the past. In addition, tell your doctor about your medical history and all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you have received any other botulinum toxin product in the last four months or in the past. Be sure your doctor knows exactly which product(s) you received and when you received them.

View Our Cosmetic Galleries »

Back To Aesthetic Services